Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss

Obstetrics and Gynecology

Volumn 116, Issue 4, 2010, Pages 997-998

  Clark, Christine A ^a   Spitzer, Karen A ^a   Laskin, Carl A ^b   Crowther, Mark R ^c   Ginsberg, Jeff S ^c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CARDIOLIPIN ANTIBODY; HEPARIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KAOLIN; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; BLOOD CLOTTING TIME; FEMALE; FETUS WASTAGE; HUMAN; LETTER; LIVE BIRTH; MONOTHERAPY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RECURRENT ABORTION; ABORTION, HABITUAL; DRUG COMBINATION; IMMUNOLOGY; META ANALYSIS (TOPIC); PREGNANCY;

ABORTION, HABITUAL; ANTIBODIES, ANTICARDIOLIPIN; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; DRUG THERAPY, COMBINATION; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; LIVE BIRTH; META-ANALYSIS AS TOPIC; PREGNANCY;

EID: 77957237746     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181f4e012     Document Type: Letter

References (8)

1. Ziakas PD, Pavlou M, Voulgarelis M. Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis. Obstet Gynecol 2010;115:1256-1262
2. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnancy women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997; 314:253-257
3. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996;174:1584-1589
4. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
5. Laskin CA, Spitzer KA, Clark CA, Crowther MR, Ginsberg JS, Hawker GA, et al. Low molecular weight hepa-rin and aspirin for recurrent pregnancy loss: results from the randomized controlled HepASA trial. J Rheumatol 2009;36:279-287
6. Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992;166:1318-1323
7. Pattison NS, Chamley LW, Birdsall M, Zanderigo AM, Liddell HS, McDou-gall J. Does aspirin have a role in improving pregnancy outcome for women with antiphospholipid antibody syndrome? A randomized clinical trial. Am J Obstet Gynecol 2000; 183:1008-1012
8. Farquharson RG, Quenby S, Greaves M. Antiphospholipid syndrome in pregnancy: A randomized, controlled trial of treatment [published erratum appears in Obstet Gynecol 2002;100:1361]. Obstet Gynecol 2002;100:408-413